Bridge Creek Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.5M | Buy |
1,970
+15
| +0.8% | +$11.2K | 0.42% | 68 |
|
|
2025
Q2 | $1.52M | Sell |
1,955
-6
| -0.3% | -$4.66K | 0.45% | 68 |
|
|
2025
Q1 | $1.62M | Sell |
1,961
-38
| -2% | -$31.6K | 0.51% | 67 |
|
|
2024
Q4 | $1.54M | Sell |
1,999
-30
| -1% | -$24.8K | 0.47% | 68 |
|
|
2024
Q3 | $1.8M | Sell |
2,029
-136
| -6% | -$122K | 0.54% | 67 |
|
|
2024
Q2 | $1.96M | Sell |
2,165
-160
| -7% | -$128K | 0.63% | 64 |
|
|
2024
Q1 | $1.81M | Sell |
2,325
-125
| -5% | -$89K | 0.58% | 66 |
|
|
2023
Q4 | $1.43M | Sell |
2,450
-122
| -5% | -$71.2K | 0.5% | 68 |
|
|
2023
Q3 | $1.38M | Sell |
2,572
-3
| -0.1% | -$1.55K | 0.52% | 69 |
|
|
2023
Q2 | $1.21M | Sell |
2,575
-25
| -1% | -$10.5K | 0.43% | 72 |
|
|
2023
Q1 | $893K | Sell |
2,600
-30
| -1% | -$10.1K | 0.34% | 74 |
|
|
2022
Q4 | $962K | Sell |
2,630
-1,160
| -31% | -$411K | 0.38% | 71 |
|
|
2022
Q3 | $1.23M | Buy |
3,790
+1,175
| +45% | +$372K | 0.53% | 64 |
|
|
2022
Q2 | $848K | Sell |
2,615
-2,535
| -49% | -$761K | 0.35% | 70 |
|
|
2022
Q1 | $1.48M | Buy |
5,150
+40
| +0.8% | +$10.3K | 0.49% | 64 |
|
|
2021
Q4 | $1.41M | Buy |
5,110
+35
| +0.7% | +$8.87K | 0.48% | 62 |
|
|
2021
Q3 | $1.17M | Buy |
5,075
+165
| +3% | +$40.7K | 0.43% | 65 |
|
|
2021
Q2 | $1.13M | Sell |
4,910
-387,537
| -99% | -$77.8M | 0.42% | 65 |
|
|
2021
Q1 | $392K | Buy |
392,447
+387,447
| +7,749% | +$75.8M | 0.15% | 85 |
|
|
2020
Q4 | $844K | Hold |
5,000
| – | – | 0.35% | 68 |
|
|
2020
Q3 | $740K | Sell |
5,000
-25
| -0.5% | -$3.87K | 0.35% | 66 |
|
|
2020
Q2 | $825K | Sell |
5,025
-75
| -1% | -$11.5K | 0.41% | 62 |
|
|
2020
Q1 | $707K | Sell |
5,100
-75
| -1% | -$10.3K | 0.42% | 60 |
|
|
2019
Q4 | $680K | Sell |
5,175
-75
| -1% | -$8.69K | 0.31% | 70 |
|
|
2019
Q3 | $587K | Sell |
5,250
-50
| -0.9% | -$5.57K | 0.28% | 72 |
|
|
2019
Q2 | $587K | Sell |
5,300
-25
| -0.5% | -$2.94K | 0.29% | 72 |
|
|
2019
Q1 | $691K | Sell |
5,325
-65
| -1% | -$7.9K | 0.35% | 65 |
|
|
2018
Q4 | $624K | Sell |
5,390
-145
| -3% | -$16.2K | 0.36% | 63 |
|
|
2018
Q3 | $593K | Sell |
5,535
-25
| -0.4% | -$2.5K | 0.3% | 66 |
|
|
2018
Q2 | $474K | Hold |
5,560
| – | – | 0.25% | 69 |
|
|
2018
Q1 | $430K | Hold |
5,560
| – | – | 0.23% | 70 |
|
|
2017
Q4 | $469K | Sell |
5,560
-25
| -0.4% | -$2.13K | 0.24% | 69 |
|
|
2017
Q3 | $478K | Sell |
5,585
-25
| -0.4% | -$2.05K | 0.25% | 66 |
|
|
2017
Q2 | $462K | Sell |
5,610
-50
| -0.9% | -$4.08K | 0.25% | 65 |
|
|
2017
Q1 | $476K | Hold |
5,660
| – | – | 0.27% | 64 |
|
|
2016
Q4 | $416K | Sell |
5,660
-2,448
| -30% | -$182K | 0.23% | 65 |
|
|
2016
Q3 | $651K | Sell |
8,108
-2
| -0% | -$160 | 0.38% | 61 |
|
|
2016
Q2 | $639K | Hold |
8,110
| – | – | 0.38% | 58 |
|
|
2016
Q1 | $584K | Hold |
8,110
| – | – | 0.34% | 60 |
|
|
2015
Q4 | $683K | Buy |
+8,110
| New | +$673K | 0.41% | 59 |
|
Other funds holding LLY
Bridge Creek Capital Management's LLY Position: Q3 2025 in Review
Bridge Creek Capital Management increased its Eli Lilly (LLY) stake by 0.77% in Q3 2025, buying an estimated $11.2K and bringing the position to 1,970 shares worth $1.5M. The position accounts for 0.42% of the portfolio, ranked #68.
Bridge Creek Capital Management first reported a position in LLY in Q4 2015 and has held it in 40 quarters since. The position peaked at $1.96M in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.
- Bridge Creek Capital Management held 1,970 shares of Eli Lilly worth $1.5M as of Q3 2025.
- Bridge Creek Capital Management bought 15 Eli Lilly shares in Q3 2025, an estimated $11.2K.
- Eli Lilly made up 0.42% of Bridge Creek Capital Management's portfolio in Q3 2025, its #68 holding.
- Bridge Creek Capital Management first reported a position in Eli Lilly in Q4 2015 and has held it in 40 quarters since.
- Bridge Creek Capital Management's Eli Lilly position peaked at $1.96M in Q2 2024.
- 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.
Based on Bridge Creek Capital Management's 13F filing for Q3 2025, filed 14 Oct 2025.